S&P/ASX 200 (INDEXASX:XJO) has bounced back from Thursday’s decline with the index rising 0.32% to 7,382 points by 12.55 pm.
This follows mixed movements in Wall Street overnight as investors digested the Federal Reserve’s hawkish tone on monetary strategy.
Locally, technology, healthcare, consumer discretionary and telecom sectors added to the gains while materials, energy and financial stocks were in the red.
Commodity stocks were weaker as most metals and oil prices softened on a stronger US dollar but iron ore managed to rise 3.3%.
Bubs Australia (ASX:BUB) shares surged 30% after announcing it will launch several of its infant formula products in the US through Walmart’s online platform.
Today’s top gainers on the ASX include Alice Queen Ltd (ASX:AQX) (+7.14%), Avz Minerals Ltd (ASX:AVZ) (+6.67%), Corazon Mining Ltd (ASX:CZN) (+12.12%), Imugene Limited (ASX:IMU)(+7.94%), Latitude Consolidated Ltd (ASX:LCD) (+6.67%), Oklo Resources Ltd (ASX:OKU) (+9.09%) and Rumble Resources Ltd (ASX:RTR) (+7.95%).
Proactive news headlines:
SUDA Pharmaceuticals licenses novel iNKT cell therapy platform from Imperial College London
Zelira Therapeutics research demonstrates significant uptake of CBD into the brain
Zelira Therapeutics Ltd (ASX:ZLD) (OTCMKTS:ZLDAF) (FRA:G1G) is buoyed that Curtin University researchers have developed a new technology that improves delivery of cannabidiol (CBD) based drugs into the brains of mice by up to 40-times.
Arafura Resources welcomes NAIF support for potential Nolans senior debt facility
Arafura Resources Limited (ASX:ARU) (OTCMKTS:ARAFF) (FRA:REB) has welcomed support from the Northern Australia Infrastructure Facility (NAIF) in relation to a potential senior debt facility as part of the funding package for its Nolans Rare Earth Project.
Danakali’s test-work confirms SOP production rates at Colluli, optimisation leads to lower opex and capex
Danakali Ltd (ASX:DNK) (LSE:DNK) (OTCMRKTS:DNKLY) says test-work conducted at its low-cost Colluli Potash Project in East Africa has confirmed production rates and outlines a path to lower operating and capital costs.
Archer Materials completes sale of Eyre Peninsula tenements to focus on quantum computing technology
Paradigm Biopharmaceuticals secures approvals for Phase 2 clinical trial treating MPS-VI subjects in Brazil with PPS
Paradigm Biopharmaceuticals Ltd (ASX:PAR) (OTCMKTS:PBIGF) has received a key regulatory approval from Brazilian National Health Surveillance Agency ANVISA for its Phase 2 clinical trial evaluating the safety and tolerability of injectable (SC) pentosan polysulfate sodium (iPPS) versus placebo in subjects with Mucopolysaccharidosis type VI (MPS VI).
Kin Mining turning to regional gold, nickel sulphide targets after fourth phase Cardinia Gold Project campaign
Musgrave Minerals RC drilling reveals thick Big Sky gold intersections up to 84 metres at Cue Project
Musgrave Minerals Ltd (ASX:MGV) (OTCMKTS:MGVMF) (FRA:6MU) has returned thick intersections in reverse circulation (RC) drilling at Big Sky prospect along a new gold corridor southwest of Lena deposit at the Cue Project in Western Australia.